CMRX

Chimerix, Inc.

NASDAQHealthcareBiotechnologyUS

USD8.54

+0.00 (+0.00%)

CEO

Michael T. Andriole

IPO Date

2013-04-11

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

Open

$8.54

Prev. Close

$8.54

Day Low

$8.54

Day High

$8.54

52W Low

$0.75

52W High

$8.55

Market Cap

$0.80B

Volume

2.55M

News SentimentNeutral

Articles

Avg Positive

6.5%

Avg Negative

11.9%

Avg Neutral

81.5%

News Feed

Chimerix, Inc. (CMRX) CEO Mike Sherman on Q2 2021 Results - Earnings Call Transcript

Chimerix to Present at 2021 Wedbush PacGrow Healthcare Conference

Chimerix Receives U.S. Food and Drug Administration Approval for TEMBEXA® (brincidofovir) for the Treatment of Smallpox